- Home
- CIK vs INO Comparison
CIK vs INO Comparison
Compare CIK & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIK
- INO
- Stock Information
- Founded
- CIK 1987
- INO 1979
- Country
- CIK United States
- INO United States
- Employees
- CIK N/A
- INO N/A
- Industry
- CIK Finance/Investors Services
- INO Medical/Dental Instruments
- Sector
- CIK Finance
- INO Health Care
- Exchange
- CIK Nasdaq
- INO Nasdaq
- Market Cap
- CIK 163.1M
- INO 136.6M
- IPO Year
- CIK N/A
- INO 1998
- Fundamental
- Price
- CIK $2.84
- INO $2.46
- Analyst Decision
- CIK
- INO Buy
- Analyst Count
- CIK 0
- INO 5
- Target Price
- CIK N/A
- INO $8.80
- AVG Volume (30 Days)
- CIK 115.4K
- INO 897.3K
- Earning Date
- CIK 01-01-0001
- INO 11-13-2025
- Dividend Yield
- CIK 9.03%
- INO N/A
- EPS Growth
- CIK N/A
- INO N/A
- EPS
- CIK N/A
- INO N/A
- Revenue
- CIK N/A
- INO $182,337.00
- Revenue This Year
- CIK N/A
- INO N/A
- Revenue Next Year
- CIK N/A
- INO $15,960.33
- P/E Ratio
- CIK N/A
- INO N/A
- Revenue Growth
- CIK N/A
- INO N/A
- 52 Week Low
- CIK $2.50
- INO $1.30
- 52 Week High
- CIK $3.19
- INO $5.83
- Technical
- Relative Strength Index (RSI)
- CIK 25.43
- INO 52.61
- Support Level
- CIK $2.82
- INO $2.35
- Resistance Level
- CIK $2.99
- INO $2.63
- Average True Range (ATR)
- CIK 0.03
- INO 0.15
- MACD
- CIK -0.01
- INO -0.03
- Stochastic Oscillator
- CIK 8.82
- INO 42.50
About CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.